Myriam Cohen-Welgryn, President, Active Cosmetics, talks about the keys to the Division’s outstanding performance, including the ways in which dermocosmetics is improving skincare, the latest big innovations and the things she was most proud of in 2021.Text version
At L’Oréal Active Cosmetics, we strongly believe that health is the future of beauty. Our portfolio of complementary skincare brands perfectly meets consumer needs for safety, performance and health, which were only heightened by the Covid-19 pandemic. Our effective, reliable, innovative products help improve both skin conditions and quality of life for patients.
The Active Cosmetics Division ended the year with exceptional growth at +31.8% like-for-like and +30.3% reported. The Division significantly outperformed a booming dermocosmetics market in 2021, with health having become a core concern for consumers. Active Cosmetics posted strong growth across all Zones, with exceptional performance in North America and North Asia. Offline sales saw a return to strong double-digit growth and online sales were exceptionally buoyant, exceeding one billion euros.
No. 1 La Roche-Posay is the brand most recommended by dermatologists worldwide
No. 1 SkinCeuticals is the top medical skincare brand worldwide
Dermocosmetics brands gather momentum
With its portfolio of brands recommended by healthcare professionals, L’Oréal Active Cosmetics continued to grow. Its innovations perfectly meet consumer needs, which have shifted in the wake of the public health crisis.Read article
Digital solutions help to build special relationships with stakeholders
Thanks to L’Oréal’s digital expertise, the Active Cosmetics Division has strengthened its relationships with stakeholders: doctors, partners and consumers – an important competitive advantage in a time when the pandemic is constantly forcing us to rethink the way we interact.Read article
Dermocosmetics: committed to the environment, healthcare and inclusion
The Active Cosmetics Division actively contributes to attaining the sustainable development goals of the L’Oréal for the Future programme via its environmental commitments and increased focus on skincare issues and inclusive dermatology.Read article
Sun care: a public health cause
A discussion with dermatologist Professor Thierry Passeron, MD, PhD, Dermatology Department, Université Côte d’Azur & INSERM, Nice, and Françoise Bernerd, PhD, Head of L’Oréal’s Light and Pigmentation Laboratory, L’Oréal Research & Innovation Fellow, on an important public health issue: the impact of UV rays on the skin and how best to protect it.
Lipikar Eczema MED: a medical treatment based on microbiome science
La Roche-Posay launched its Lipikar Eczema MED cream: a medical treatment that combats eczema, a common skin condition among children which manifests as patches of dry, itchy skin. The cream is enriched with endobioma, an ingredient developed thanks to advances in microbiome science. This unique ingredient specifically targets the main bacteria responsible for the inflammation while preserving other bacteria which are essential for healthy skin. Results are visible in just three days. La Roche-Posay laboratories continue to explore the microbiome and harness the latest scientific advances to improve treatment for several skin conditions.